- Issuer ticker
-
NERV
- Reported as of
-
08 Aug 2022
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
3
- Accepted by SEC
-
10 Aug 2022, 14:07:07 UTC
Reporting owner
1 detail
- Reporting owner signature
-
Suejean Mott
Key filing fact
BARCLAYS PLC filed Form 3 for Minerva Neurosciences, Inc. (NERV) on 10 Aug 2022.
Key facts
- This page summarizes BARCLAYS PLC's Form 3 filing for Minerva Neurosciences, Inc. (NERV).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Aug 2022, 14:07.
Change
- Previous filing in this sequence was filed on 19 Jul 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
Ownership activity is grounded in SEC Form 3 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NERV
holding
Common Stock, $0.0001 par value per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 408,430
- Date
- 08 Aug 2022
- Ownership
- By Barclays Bank PLC
NERV
holding
Common Stock, $0.0001 par value per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 196,800
- Date
- 08 Aug 2022
- Ownership
- By Barclays Capital Inc.
* marks a reported price that did not pass the local price check.
SEC remarks
(a) Beneficially owned ordinary shares are comprised in Units, each consisting of one ordinary share (b) Name of Person Filing: (1) Barclays PLC (2) Barclays Bank PLC (controlled by Barclays PLC) (3) Barclays Capital, Inc. (controlled by Barclays PLC) (c) Address of Principal Business Office or, if non, Residence: (1) Barclays PLC 1 Churchill Place London, E14 5HP, England (2) Barclays Bank PLC 1 Churchill Place London, E14 5HP, England (3) Barclays Capital, Inc. 745 7th Avenue New York, New York 10019 United States